News & Analysis on Clinical Trial Services & Contract Research And Development
As proof of microdosing's potential in drug development, bioanalytical CRO, Xceleron, is to lead the European Union Microdose AMS Partnership Programme (EUMAPP) having additionally been awarded €2.1 million to further develop this technology.
Ingenuity Systems have launched the Ingenuity Pathways Analysis (IPA) 3.1, a web-based software application that enables biologists and bioinformaticians to understand biological mechanisms, pathways and functions.
Covance closed 2005 on a high after net revenues climbed 16.9 per cent from 2004 to reach $1.19 bn (€1 bn). The current trend towards outsourcing R&D, coupled with increased productivity and repeat business has fuelled the company's robust performance.
French pharmaceutical company, Sanofi-Aventis, reported an increase in sales for the fourth quarter with its vaccine business continuing to impress. The company's performance precedes two upcoming decisions later this year that will greatly impact its...
Researchers have come up with definitive proof that proteins can be custom-designed for a new and pre-determined activity, signalling a new direction in drug production as well as having relevance to the biotechnological and medicinal industry.
Pharmion and MethylGene has announced the formation of an international licensing agreement potentially worth $272 million (€224 million) for new class of compounds that inhibits gene expression providing a tumour and haematological malignancy...
As contract research organisations (CROs) continue to search for cost-effective countries in which to operate, the clinical trials market is increasingly expanding into emerging economies. Central and Eastern Europe are continuing to experience strong...